Evidence map›Paper›PMID 40330874›Full record

ArticleRespiratory medicine case reports2025

Successful stent removal after chemoradiotherapy followed by durvalumab for locally advanced non-small cell lung cancer with airway stenosis: A report of three cases.

Yuki Takigawa, Ken Sato, Daisuke Minami, Kenichiro Kudo, Shoichiro Matsumoto, Miho Fujiwara, Takeru Ichikawa, Tomoyoshi Inoue, Suzuka Matsuoka, Hiromi Watanabe and 5 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Respiratory medicine case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yuki TakigawaDepartment of Respiratory Medicine, National Hospital Organization Okayama Medical Center, 701-1192, Okayama, Japan.
Ken SatoDepartment of Respiratory Medicine, National Hospital Organization Okayama Medical Center, 701-1192, Okayama, Japan.
Daisuke MinamiDepartment of Respiratory Medicine, National Hospital Organization Okayama Medical Center, 701-1192, Okayama, Japan.
Kenichiro KudoDepartment of Respiratory Medicine, National Hospital Organization Okayama Medical Center, 701-1192, Okayama, Japan.
Shoichiro MatsumotoDepartment of Respiratory Medicine, National Hospital Organization Okayama Medical Center, 701-1192, Okayama, Japan.
Miho FujiwaraDepartment of Respiratory Medicine, National Hospital Organization Okayama Medical Center, 701-1192, Okayama, Japan.
Takeru IchikawaDepartment of Respiratory Medicine, National Hospital Organization Okayama Medical Center, 701-1192, Okayama, Japan.
Tomoyoshi InoueDepartment of Respiratory Medicine, National Hospital Organization Okayama Medical Center, 701-1192, Okayama, Japan.
Suzuka MatsuokaDepartment of Respiratory Medicine, National Hospital Organization Okayama Medical Center, 701-1192, Okayama, Japan.
Hiromi WatanabeDepartment of Respiratory Medicine, National Hospital Organization Okayama Medical Center, 701-1192, Okayama, Japan.
Akiko SatoDepartment of Respiratory Medicine, National Hospital Organization Okayama Medical Center, 701-1192, Okayama, Japan.
Hiroyasu ShodaDepartment of Respiratory Medicine, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
Nobuhisa IshikawaDepartment of Respiratory Medicine, Hiroshima Prefectural Hospital, Hiroshima, Japan.
Keiichi FujiwaraDepartment of Respiratory Medicine, National Hospital Organization Okayama Medical Center, 701-1192, Okayama, Japan.
Takuo ShibayamaDepartment of Respiratory Medicine, National Hospital Organization Okayama Medical Center, 701-1192, Okayama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Airway stents improve respiratory conditions and Eastern Cooperative Oncology Group Performance Status scores in cases of airway stenosis, as observed in patients with stage III non-small cell lung cancer (NSCLC) who experience prolonged survival after undergoing chemoradiotherapy followed by durvalumab treatment. Herein, we report three cases of severe airway stenosis due to stage III NSCLC in patients who underwent airway stenting and subsequent stent removal after chemoradiotherapy and durvalumab administration. The number of stents removed will likely increase in the future due to the high response rates to molecular drugs and immune checkpoint inhibitors.

Indexed as

AERO stentChemoradiotherapyDumon Y-StentDurvalumabStent removal

Identifiers

PMID40330874
PMCPMC12051515

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.